Founded | 1991 |
---|---|
Focus | Exploring ethical issues in biology and medicine |
Location |
|
Website | Nuffield Council on Bioethics |
The Nuffield Council on Bioethics is a UK-based independent charitable body, which examines and reports on bioethical issues raised by new advances in biological and medical research. Established in 1991, the Council is funded by the Nuffield Foundation, the Medical Research Council and the Wellcome Trust.[1] The Council has been described by the media as a 'leading ethics watchdog',[2] which 'never shrinks from the unthinkable'.[3]
The Nuffield Council on Bioethics was set up in response to concerns about the lack of a national organization responsible for evaluating the ethical implications of developments in biomedicine and biotechnology.[4] Its terms of reference[5] are:
The Council selects topics to examine through a horizon scanning programme, which aims to identify developments relevant to biological and medical research. Members of the Council meet quarterly to discuss and contribute to ongoing work, review recent advances in medical and biological research that raise ethical questions and choose topics for further exploration. The Council is well known for its in-depth inquiries which usually take 18–24 months and are overseen by an expert working group, informed by extensive consultation and research.[6]
The Chair of the Nuffield Council on Bioethics is appointed by the Nuffield Foundation in consultation with the other funders. Chairs are appointed for five years. Council members are drawn from relevant fields of expertise including science, medicine, sociology, philosophy and law, for an initial period of three years, with the possibility of an additional three-year term. When vacancies arise, the council advertises widely. The council's membership advisory group considers and makes recommendations to the council on future members selected from the respondents to advertisements.[7]
The governing board was established by the funders of the council in 2017 and holds the principal responsibility for the governance of the NCOB, overseeing its operations and providing assurance that it is working within the terms of its grant.[8] The chair (distinct from the chair of the council) is Professor Jane Macnaughton (Durham University) with other members Dr Sarion Bowers (University of Cambridge), Professor Adam Hedgecoe (Cardiff University), Dr Katherine Littler (World Health Organisation) and three representatives of the funders.[9]
Danielle Hamm was appointed in June 2021
Former Directors:
Current[12]
Previous members[12]
The Council's recommendations to policy makers have often been described as 'influential'.[48][49][50][51][52][53]
The Council was entirely funded by the Nuffield Foundation from 1991 to 1994. Since 1994, the Council has been jointly funded by the Nuffield Foundation, the Medical Research Council and The Wellcome Trust on a five-year rolling system.[54] Towards the end of each five-year period, a process of external review is a condition of continued support. Funding has been confirmed until 2022 following the satisfactory completion of the latest funding bid.[55]
The Council takes the view that its terms of reference do not require it to adopt the same ethical framework or set of principles in all reports. The Council is therefore not bound by the values of particular schools of philosophy (for example, utilitarianism, deontology, virtue ethics) or approaches in bioethics, such as the 'four principles of bioethics' (autonomy, justice, beneficence, non-maleficence), or the Barcelona Principles (autonomy, dignity, integrity, vulnerability).[56]
In 2006-7, John Harris, Professor of Bioethics at the University of Manchester, and Dr Sarah Chan carried out an external review of the way ethical frameworks, principles, norms and guiding concepts feature in the Council's publications.[57] The authors found that the ethical frameworks used in the Council's publications had become increasingly explicit and transparent.